Leadership Transition - Merit Medical Systems, Inc. has appointed Martha Aronson as the new President and CEO, effective October 3, 2025, while Fred P. Lampropoulos will continue as Chairman of the Board until that date [1][2] - Lampropoulos expressed confidence in Aronson's ability to lead the company, highlighting her qualifications and experience in global healthcare [2] - Aronson has a strong background, having held leadership roles at Ecolab, Hill-Rom, and Medtronic, and has served on various boards [2][3] Financial Performance - Merit announced preliminary unaudited revenue for Q2 2025 in the range of approximately $380 to $384 million, representing a projected increase of about 12% to 14% compared to Q2 2024 [5] - The preliminary constant currency revenue for the same period increased by approximately 11% to 13% year-over-year [5] - The impact of foreign exchange on preliminary revenue was a decrease of $2.3 million [12] Company Overview - Founded in 1987, Merit Medical specializes in developing, manufacturing, and distributing proprietary disposable medical devices for various medical procedures [13] - The company serves hospitals globally with a workforce of approximately 7,300 employees [13]

Company Overview - Synovus has a 135-year history of commercial and retail banking in the Southeast U S [6] - The company has $59 billion in assets, $44 billion in loans, and $50 billion in deposits [6] - Synovus completed the transition to a singularly branded Synovus name and platform in 2018 [6] Growth and Market Position - Growth markets account for 55% of loans outstanding and 42% of core deposits [16] - The company is expanding its presence in growing Southeast markets [17] - Since 2019, the company has increased RM count in Corporate & Investment Banking by 24% [45] Financial Performance and Strategy - The company is focused on long-term shareholder value creation [19] - Recent strategies are PPNR accretive and supportive to growth [27] - Wholesale Funding/Assets decreased by 14% from 2Q23 to 3Q23 [28] - Office CRE Loans/Total Loans decreased by 36% from 2Q23 to 3Q23 [28] - The company anticipates relatively flat adjusted expenses in 2024, with a 2022 baseline of $116 billion and a 2023 estimate of $122 billion [38]

Financial Performance & Results - Q4 FY2025 GAAP Net Revenue was $1583 million, exceeding the guidance range of $1519 million to $1619 million[6] - Q4 FY2025 Net Bookings reached $1582 million, hitting the top of the guidance range of $1480 million to $1580 million[8] - FY2025 GAAP Net Revenue was $5634 million, within the guidance of $5570 million to $5670 million[11] - FY2025 Net Bookings totaled $5648 million, also at the top of the guidance range of $5550 million to $5650 million[13] - The company projects FY2026 Net Bookings to range from $5900 million to $6000 million, representing approximately 5% growth over FY2025 at the midpoint[27] Recurrent Consumer Spending (RCS) - Q4 FY2025 Recurrent Consumer Spending (RCS) grew by 14% year-over-year, significantly exceeding guidance[8] - FY2025 Recurrent Consumer Spending (RCS) increased by 7% year-over-year, exceeding the company's outlook[13] - The company expects FY2026 Recurrent Consumer Spending (RCS) to be flat compared to FY2025[27] - The company projects Q1 FY2026 Recurrent Consumer Spending (RCS) to increase by approximately 7% year-over-year[32] Fiscal Year 2026 Guidance - The company anticipates GAAP Net Revenue between $5950 million and $6050 million for FY2026[23] - Operating expenses for FY2026 are projected to be between $3780 million and $3800 million[23] - The company expects a GAAP Net Loss between $499 million and $439 million for FY2026[23]

Federal Signal Q1 2025 Earnings Call April 30, 2025 Jennifer Sherman, President & Chief Executive Officer Ian Hudson, SVP, Chief Financial Officer Felix Boeschen, VP, Corporate Strategy & Investor Relations Safe Harbor This presentation contains unaudited financial information and various forward-looking statements as of the date hereof and we undertake no obligation to update these forward- looking statements regardless of new developments or otherwise. Statements in this presentation that are not historic ...